Regulatory authorities in the US are investigating a possible link between the new Pfizer/BioNTech bivalent COVID-19 booster vaccine and strokes in people aged 65 or over, but still recommend the ...

US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years ...